Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse-Reference-Cited by-同舟云学术

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse

Published:2008-12-23 Issue:5 Volume:49 Page:1442-1448
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Basso Monica,Giannini Edoardo G.,Torre Francesco,Blanchi Sabrina,Savarino Vincenzo,Picciotto Antonino

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.22810/fullpdf

Reference24 articles.

1. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C 2002 (June 10-12, 2002);Gastroenterology,2002

2. Monitoring of viral levels during therapy of hepatitis C;Davis;HEPATOLOGY,2002

3. Review article: indicators and predictors of response to anti-viral therapy in chronic hepatitis C;Lee;Aliment Pharmacol Ther,2003

4. Early predictors of response to treatment in patients with chronic hepatitis C;Civeira;J Hepatol,1999

5. Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?;Hung;J Gastroenterol Hepatol,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment;The Open Microbiology Journal;2022-07-20

2. Interferon-Based Hepatitis C Antiviral Treatment Outcomes May Be Predicted by Alanine Aminotransferase Levels;Canadian Journal of Gastroenterology and Hepatology;2015

3. Advanced Hepatic Fibrosis and Steatosis Are Associated With Persistent Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for Hepatitis C Virus RNA During Pegylated Interferon Plus Ribavirin Therapy;Journal of Infectious Diseases;2014-11-11

4. Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials);Drug Safety;2014-10-29

5. Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response;PLoS ONE;2014-06-17